NasdaqGS - Delayed Quote USD
Y-mAbs Therapeutics, Inc. (YMAB)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:20 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
27.6
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
KYMR Kymera Therapeutics, Inc. | 28 | -- | -- | -- |
PTGX Protagonist Therapeutics, Inc. | 28 | -- | -- | -- |
YMAB Y-mAbs Therapeutics, Inc. | 28 | -- | -- | -- |
CORT Corcept Therapeutics Incorporat | 28 | -- | -- | -- |
BTAI BioXcel Therapeutics, Inc. | 28 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
YMAB
Category Average
1 Low Controversy Level
None 4 Severe
1.0 YMAB
0.4 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
REPL Replimune Group, Inc.
11.53
+1.95%
STOK Stoke Therapeutics, Inc.
13.00
-2.03%
PEPG PepGen Inc.
8.94
+0.79%
MRSN Mersana Therapeutics, Inc.
2.1000
-0.47%
STRO Sutro Biopharma, Inc.
3.7300
+0.54%
AGIO Agios Pharmaceuticals, Inc.
45.50
+3.08%
SYRE Spyre Therapeutics, Inc.
32.76
0.00%
XNCR Xencor, Inc.
21.78
+1.97%
IKNA Ikena Oncology, Inc.
1.7100
0.00%
ORIC ORIC Pharmaceuticals, Inc.
9.45
+3.28%